CA1282004C - Inactivation of bacterial endotoxins - Google Patents

Inactivation of bacterial endotoxins

Info

Publication number
CA1282004C
CA1282004C CA000516466A CA516466A CA1282004C CA 1282004 C CA1282004 C CA 1282004C CA 000516466 A CA000516466 A CA 000516466A CA 516466 A CA516466 A CA 516466A CA 1282004 C CA1282004 C CA 1282004C
Authority
CA
Canada
Prior art keywords
compound
present
peroxydiphosphate
peroxydiphos
phate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000516466A
Other languages
English (en)
French (fr)
Inventor
Abdul Gaffar
Edward J. Coleman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colgate Palmolive Co
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Application granted granted Critical
Publication of CA1282004C publication Critical patent/CA1282004C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA000516466A 1985-08-22 1986-08-21 Inactivation of bacterial endotoxins Expired - Lifetime CA1282004C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US76839685A 1985-08-22 1985-08-22
US768,396 1985-08-22
US85191586A 1986-04-14 1986-04-14
US851915 1986-04-14

Publications (1)

Publication Number Publication Date
CA1282004C true CA1282004C (en) 1991-03-26

Family

ID=27118049

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000516466A Expired - Lifetime CA1282004C (en) 1985-08-22 1986-08-21 Inactivation of bacterial endotoxins

Country Status (12)

Country Link
BE (1) BE905319A (enrdf_load_stackoverflow)
CA (1) CA1282004C (enrdf_load_stackoverflow)
CH (1) CH670046A5 (enrdf_load_stackoverflow)
DE (1) DE3627759A1 (enrdf_load_stackoverflow)
DK (1) DK168513B1 (enrdf_load_stackoverflow)
FR (1) FR2586351B1 (enrdf_load_stackoverflow)
GB (1) GB2180451B (enrdf_load_stackoverflow)
HK (1) HK593A (enrdf_load_stackoverflow)
IT (1) IT1196587B (enrdf_load_stackoverflow)
NL (1) NL8602140A (enrdf_load_stackoverflow)
SE (1) SE468626B (enrdf_load_stackoverflow)
SG (1) SG108892G (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586350B1 (fr) * 1985-08-22 1992-05-15 Colgate Palmolive Co Composition pharmaceutique a base de peroxodiphosphate pour l'inhibition de la secretion d'hormone parathyroidienne
DE4201858A1 (de) * 1992-01-24 1993-07-29 Renschler Aloys Dr Med Mittel zur behandlung maligner zellen
NO20024880L (no) * 2002-03-19 2003-09-22 Per Hamre Sammensetning inneholdende fosfat

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041149A (en) * 1976-01-12 1977-08-09 Colgate-Palmolive Company Composition and method of controlling and preventing mouth odor
US4430325A (en) * 1981-12-23 1984-02-07 Colgate-Palmolive Company Topical treatment of skin lesions
US4975423A (en) * 1984-06-27 1990-12-04 Colgate-Palmolive Company Inhibition of tumor development
DK168191B1 (da) * 1984-06-27 1994-02-28 Colgate Palmolive Co Anvendelse af peroxydiphosphater til fremstilling af farmaceutiske tabletter eller farmaceutiske vandige opløsninger

Also Published As

Publication number Publication date
FR2586351B1 (fr) 1991-10-18
IT8648389A0 (it) 1986-08-19
GB2180451B (en) 1989-10-18
DE3627759A1 (de) 1987-03-19
DK402086A (da) 1987-02-23
GB8620482D0 (en) 1986-10-01
SG108892G (en) 1992-12-24
DK168513B1 (da) 1994-04-11
IT8648389A1 (it) 1988-02-19
BE905319A (fr) 1987-02-23
SE8603486D0 (sv) 1986-08-19
SE8603486L (sv) 1987-02-23
FR2586351A1 (fr) 1987-02-27
HK593A (en) 1993-01-15
SE468626B (sv) 1993-02-22
NL8602140A (nl) 1987-03-16
DK402086D0 (da) 1986-08-22
IT1196587B (it) 1988-11-16
CH670046A5 (enrdf_load_stackoverflow) 1989-05-12
GB2180451A (en) 1987-04-01

Similar Documents

Publication Publication Date Title
DE3887233T2 (de) Hemmung von Mineralabsetzung mit Hilfe von polyanionischen/hydrophobischen Peptiden und deren Derivaten.
TWI307278B (en) Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
HU227956B1 (en) Use of factor xa inhibiting oligosaccharide with a platelet antiaggregating agent for treating arterial thrombosis
US3851056A (en) Method of depressing fatty acids and triglycerides
MD1688F2 (en) Benzothiophene, benzofuran and indolethiazepinons, oxazepinons and diazepinons, pharmaceutical composition, method of inhibiting the leucocytes adherence to the endothelial cells for inflammatory diseases treatment and method of treatment of the mammals affected by the HIV infection
Francis et al. Chemical agents in the control of calcification processes in biological systems
AU638251B2 (en) Method for protection from azt side effects and toxicity
CA1282004C (en) Inactivation of bacterial endotoxins
US4806532A (en) Inhibition of epithelial phosphate transport
EP0302263B1 (en) Therapeutic composition for combatting aids
US5034383A (en) Inactivation of bacterial endotoxins using peroxy-diphosphate compoounds
EP0338042B1 (en) Composition and method for treating hepatitis virus infections using 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil
US2823163A (en) Antivaginitis process and cation exchange resin composition
FI84697C (fi) Foerfarande foer framstaellning av en farmakologisk komposition med derivat av peroxidifosforsyra.
FI83083B (fi) Foerfarande foer framstaellning av ett mononatriumsalt av cefonicid.
EP0623623B1 (en) 2-aminoethanesulfonic acid/zinc complex
US5028439A (en) Inhibition of parathyroid hormone secretion
US5037804A (en) Agent for preventing and treating thrombocytopenia
JPS6212766B2 (enrdf_load_stackoverflow)
EP0549597A1 (en) Anionic furanose derivatives, methods of making and using the same
JPS62123121A (ja) 細菌内毒素の不活化方法
GB2179255A (en) Inhibition of parathyroid hormone secretion
JPH01102026A (ja) エイズの治療剤
AU641540C (en) Anionic furanose derivatives, methods of making and using the same
CA1316830C (en) Agent for treating or preventing thrombocytopenia

Legal Events

Date Code Title Description
MKLA Lapsed